Latest Breaking News On - Net loss attributable to synthetic biologics inc - Page 1 : comparemela.com

Synthetic Biologics Reports Second Quarter 2022 Operational Highlights and Financial Results

11.08.2022 - -Prioritizing the advancement of novel oncolytic adenovirus (OV) platform- -Cash balance as of August 1, 2022 of $53.5 million, including the additional $3 million in gross proceeds from convertible preferred financing extends funding for business .

United statesStevena shallcrossChris calabreseLifesci advisorsCredit opportunity master fundProgram developmentsUniversity of leedsSynthetic biologics incNet loss attributable to synthetic biologics incChief executive officerSynthetic biologicEnded juneOpportunity master fundSynthetic biologicsPrivate securities litigation reform actSynthetic biologic annual report

Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

/PRNewswire/ Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed.

United statesStevena shallcrossCompany phaseWashington university school of medicineNet loss attributable to synthetic biologics incSafety monitoring committeeLouis washington universitySynthetic biologics incPrnewswire synthetic biologics incClinical developmentChief executive officerWashington university schoolMassachusetts generalEnded septemberSynthetic biologicsSynthetic biologic

Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

/PRNewswire/ Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed.

United statesStevena shallcrossCompany phaseWashington university school of medicineNet loss attributable to synthetic biologics incSafety monitoring committeeLouis washington universitySynthetic biologics incPrnewswire synthetic biologics incClinical developmentChief executive officerWashington university schoolMassachusetts generalEnded septemberSynthetic biologicsSynthetic biologic

Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesStevena shallcrossCompany phaseWashington university school of medicineNet loss attributable to synthetic biologics incWashington universitySafety monitoring committeeLouis washington universityAmerican company guide theSynthetic biologics incClinical developmentSynthetic biologicsChief executive officerWashington university schoolMassachusetts generalCompany guide